Per-gram cost of medication is by itself a poor indicator for comparing costs of different psoriasis treatments: A retrospective cohort study of the cost of psoriasis treatment with topical corticosteroids versus topical calcipotriene

Journal of Cutaneous Medicine and Surgery

Volumn 4, Issue 3, 2000, Pages 121-125

  Feldman, Steven R ^a   Sahu, Sadhvi ^b   Fleischer Jr , Alan B ^a   Dezii, Christopher M ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Outcomes Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; BODY SURFACE; COHORT ANALYSIS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DISEASE SEVERITY; DRUG COST; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS;

EID: 0033856182     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/120347540000400302     Document Type: Article

References (22)

1. Psoriasis
2. Disease severity measures in a population of psoriasis patients: The symptoms of psoriasis correlate with self-administered psoriasis area severity index scores
3. The physical, psychological and social impact of psoriasis
4. The economic impact of psoriasis increases with psoriasis severity
5. Psoriasis causes as much disability as other major medical diseases
6. Effectiveness of topical therapy for psoriasis: Results of a national survey
7. Topical corticosteroids
8. Topical therapy for psoriasis
9. Tars and anthralins
10. Calcipotriene ointment 0.005% for psoriasis: A safety and efficacy study
11. Comparative study of calcipotriene (MC 903) ointment and fluocinonide ointment in the treatment of psoriasis
12. Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis
13. Predictors of a medical-offset effect among patients receiving antidepressant therapy
14. Vasoconstrictor assay-specific applications
15. There are three, not seven, potency classes of topical corticosteroids
16. A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis
17. Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: Effects on the duration of improvement
18. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis
19. Increasing use of combination therapy in the treatment of psoriasis
20. The annual cost of psoriasis